We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
Cap. Flow
+$1.03B
Cap. Flow %
14.89%
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$73.4M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$72M
3
JNJ icon
Johnson & Johnson
JNJ
+$64.2M
4
CL icon
Colgate-Palmolive
CL
+$62.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$52.1M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$73.1M
2
FRPT icon
Freshpet
FRPT
+$58.3M
3
PARA
Paramount Global Class B
PARA
+$48M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$43.7M
5
KYNB
Kyntra Bio
KYNB
+$32.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Consumer Staples 5.26%
3 Consumer Discretionary 4.88%
4 Technology 4.62%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CINGW icon
201
Cingulate Inc Warrants
CINGW
$35.4K
$70.2K ﹤0.01%
410,001
+1
+0% –
RVSNW icon
202
Rail Vision Ltd Warrant
RVSNW
$736K
$66.4K ﹤0.01%
1,089,501
+1
+0% –
ONFOW icon
203
Onfolio Holdings Warrant
ONFOW
$75.1K
$65.6K ﹤0.01%
400,001
+1
+0% –
BIAFW icon
204
bioAffinity Technologies
BIAFW
$61.2K ﹤0.01%
204,083
+1
+0% –
IVDAW icon
205
Iveda Solutions Warrant
IVDAW
$53.9K
$56.8K ﹤0.01%
145,001
+1
+0% –
BNCWW
206
CEA Industries Inc Warrant
BNCWW
$44.7K
$55.5K ﹤0.01%
700,001
+1
+0% –
SVREW
207
SaverOne 2014 Ltd Warrant
SVREW
$53.1K ﹤0.01%
242,101
+1
+0% –
SWAGW icon
208
Stran & Company Warrant
SWAGW
$91.1K
$51.7K ﹤0.01%
545,001
+1
+0% –
LL
209
DELISTED
LL Flooring Holdings, Inc.
LL
$51.2K ﹤0.01%
+13,478
New +$68.7K
DFSCW
210
DEFSEC Technologies Warrant
DFSCW
$46.8K ﹤0.01%
120,001
+1
+0% +$1
MOBBW
211
Mobilicom Ltd Warrants
MOBBW
$2.83B
$43.6K ﹤0.01%
242,101
+1
+0% –
NEXRW
212
Nexera Technologies Ltd Warrant
NEXRW
$41.4K
$41.1K ﹤0.01%
480,770
+1
+0% –
KTTAW icon
213
Pasithea Therapeutics Warrants
KTTAW
$21.4K
$40K ﹤0.01%
1,000,001
+1
+0% –
ACONW icon
214
Aclarion Warrant
ACONW
$49.2K
$38.5K ﹤0.01%
550,001
+1
+0% –
GROMW
215
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$32.3K ﹤0.01%
24,101
+2
+0% +$4
NXLIW
216
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$30.9K ﹤0.01%
325,001
+1
+0% –
LCFYW icon
217
Locafy Ltd Warrant
LCFYW
$28.8K ﹤0.01%
12,122
+1
+0% +$3
GMVDW
218
DELISTED
G Medical Innovations Holdings Ltd. Warrants
GMVDW
$25.1K ﹤0.01%
28,572
+1
+0% +$1
AREBW
219
DELISTED
American Rebel Holdings Warrants
AREBW
$14.9K ﹤0.01%
4,819
– –
AIMDW icon
220
Ainos Warrants
AIMDW
$7.58K ﹤0.01%
25,001
+1
+0% –
EDBLW
221
Edible Garden AG Warrant
EDBLW
$66.4K
$4.77K ﹤0.01%
26,668
-773,332
-97% -$122K
TCBPW
222
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$3.76K ﹤0.01%
37,648
+1
+0% –
MDGSW
223
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$2.53K ﹤0.01%
85,715
+1
+0% –
SQLLW
224
DELISTED
SeqLL Inc. Warrant
SQLLW
$2.51K ﹤0.01%
50,001
+1
+0% –
DRMAW icon
225
Dermata Therapeutics Warrant
DRMAW
$14.1K
$1.01K ﹤0.01%
20,314
-304,686
-94% -$10.8K
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.

  • Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
  • Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
  • Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
  • Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
  • Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.